0001136261-20-000120.txt : 20200515 0001136261-20-000120.hdr.sgml : 20200515 20200515171900 ACCESSION NUMBER: 0001136261-20-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dunn Judith CENTRAL INDEX KEY: 0001811904 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 20886815 MAIL ADDRESS: STREET 1: C/O SEELOS THERAPEUTICS, INC. STREET 2: 300 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (646) 998-6475 MAIL ADDRESS: STREET 1: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20100914 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-05-15 0 0001017491 SEELOS THERAPEUTICS, INC. SEEL 0001811904 Dunn Judith C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022 1 0 0 0 Stock Option (right to buy) 0.97 2020-05-15 4 A 0 24000 0 A 2030-05-15 Common Stock 24000 24000 D Stock Option (right to buy) 0.97 2020-05-15 4 A 0 16000 0 A 2030-05-15 Common Stock 16000 16000 D 1/3rd of the shares subject to the option shall vest on May 15, 2021, and 1/36th of the shares subject to the option shall vest monthly thereafter. 1/12th of the shares subject to the option shall vest on June 15, 2020, and 1/12th of the shares subject to the option shall vest monthly thereafter. /s/ Raj Mehra, as attorney-in-fact for Judith Dunn 2020-05-15